BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33617953)

  • 41. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
    Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
    Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death.
    Enzinger AC; Zhang B; Weeks JC; Prigerson HG
    J Pain Symptom Manage; 2014 Jun; 47(6):1078-90. PubMed ID: 24099894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of a Self-Monitoring Quality of Life Intervention For Patients with Cancer Receiving Palliative Care: A Randomized Controlled Clinical Trial.
    Matsuda A; Yamada Y; Ishizuka N; Matsushima E; Kobayashi K; Ohkubo T; Yamaoka K
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2795-2802. PubMed ID: 31554379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-intensity end-of-life care among children, adolescents, and young adults with cancer who die in the hospital: A population-based study from the French national hospital database.
    Revon-Rivière G; Pauly V; Baumstarck K; Bernard C; André N; Gentet JC; Seyler C; Fond G; Orleans V; Michel G; Auquier P; Boyer L
    Cancer; 2019 Jul; 125(13):2300-2308. PubMed ID: 30913309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
    Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer.
    Greer JA; Pirl WF; Jackson VA; Muzikansky A; Lennes IT; Heist RS; Gallagher ER; Temel JS
    J Clin Oncol; 2012 Feb; 30(4):394-400. PubMed ID: 22203758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patterns of Symptom Management Medication Receipt at End-of-Life Among Medicare Beneficiaries With Lung Cancer.
    Saphire ML; Prsic EH; Canavan ME; Wang SJ; Presley CJ; Davidoff AJ
    J Pain Symptom Manage; 2020 Apr; 59(4):767-777.e1. PubMed ID: 31778783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study.
    Ahmadi Z; Wysham NG; Lundström S; Janson C; Currow DC; Ekström M
    Thorax; 2016 Jun; 71(6):510-6. PubMed ID: 26865603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial.
    Gunatilake S; Brims FJ; Fogg C; Lawrie I; Maskell N; Forbes K; Rahman N; Morris S; Ogollah R; Gerry S; Peake M; Darlison L; Chauhan AJ
    Trials; 2014 Sep; 15():367. PubMed ID: 25238873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early Palliative Care in Patients With Non-Small-Cell Lung Cancer: A Randomized Controlled Trial in Southwest China.
    Chen M; Yang L; Yu H; Yu H; Wang S; Tian L; Liu S
    Am J Hosp Palliat Care; 2022 Nov; 39(11):1304-1311. PubMed ID: 35088602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: a retrospective chart review.
    Bükki J; Scherbel J; Stiel S; Klein C; Meidenbauer N; Ostgathe C
    Support Care Cancer; 2013 Jun; 21(6):1743-50. PubMed ID: 23344656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rural/urban differences in health care utilization and place of death for persons with respiratory illness in the last year of life.
    Goodridge D; Lawson J; Rennie D; Marciniuk D
    Rural Remote Health; 2010; 10(2):1349. PubMed ID: 20438281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Components of early outpatient palliative care consultation in patients with metastatic nonsmall cell lung cancer.
    Jacobsen J; Jackson V; Dahlin C; Greer J; Perez-Cruz P; Billings JA; Pirl W; Temel J
    J Palliat Med; 2011 Apr; 14(4):459-64. PubMed ID: 21417739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Addressing the Palliative Setting in Advanced Lung Cancer Should Not Remain a Barrier: A Multicenter Study.
    Janssens A; Derijcke S; Lefebure A; Vandenbroucke E; Surmont V; Coeman D; Galdermans D; Morel AM; Hiddinga BI; van Meerbeeck JP
    Clin Lung Cancer; 2017 Jul; 18(4):e283-e287. PubMed ID: 28189594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spiritual Care, Pain Reduction, and Preferred Place of Death Among Advanced Cancer Patients in Soweto, South Africa.
    Ratshikana-Moloko M; Ayeni O; Tsitsi JM; Wong ML; Jacobson JS; Neugut AI; Sobekwa M; Joffe M; Mmoledi K; Blanchard CL; Mapanga W; Ruff P; Cubasch H; O'Neil DS; Balboni TA; Prigerson HG
    J Pain Symptom Manage; 2020 Jul; 60(1):37-47. PubMed ID: 32045675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Communication Differences between Oncologists and Palliative Care Clinicians: A Qualitative Analysis of Early, Integrated Palliative Care in Patients with Advanced Cancer.
    Thomas TH; Jackson VA; Carlson H; Rinaldi S; Sousa A; Hansen A; Kamdar M; Jacobsen J; Park ER; Pirl WF; Temel JS; Greer JA
    J Palliat Med; 2019 Jan; 22(1):41-49. PubMed ID: 30359204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Pavel ME; Singh S; Strosberg JR; Bubuteishvili-Pacaud L; Degtyarev E; Neary MP; Carnaghi C; Tomasek J; Wolin E; Raderer M; Lahner H; Valle JW; Pommier R; Van Cutsem E; Tesselaar MET; Fave GD; Buzzoni R; Hunger M; Eriksson J; Cella D; Ricci JF; Fazio N; Kulke MH; Yao JC
    Lancet Oncol; 2017 Oct; 18(10):1411-1422. PubMed ID: 28838862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality of End-of-Life Care for People with Advanced Non-Small Cell Lung Cancer in Ontario: A Population-Based Study.
    Goldie CL; Nguyen P; Robinson AG; Goldie CE; Kircher CE; Hanna TP
    Curr Oncol; 2021 Aug; 28(5):3297-3315. PubMed ID: 34590598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors related to and economic implications of inhospital death in German lung cancer patients - results of a Nationwide health insurance claims data based study.
    Deckert K; Walter J; Schwarzkopf L
    BMC Health Serv Res; 2018 Oct; 18(1):793. PubMed ID: 30340487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.